2005-2019年湛江市主要血源及性传播疾病流行特征分析与模型预测

寇晓杰; 张泽旭; 倪进东; 陈惠达; 张炳松; 梁力中; 曾海; 曾志嵘

doi:10.16462/j.cnki.zhjbkz.2023.07.004

2005-2019年湛江市主要血源及性传播疾病流行特征分析与模型预测

doi: 10.16462/j.cnki.zhjbkz.2023.07.004

寇晓杰¹,
张泽旭¹,
倪进东^{1, 5},
陈惠达¹,
张炳松²,
梁力中³,
曾海⁴,
曾志嵘^5, ,

1.
广东医科大学公共卫生学院流行病与卫生统计学系，东莞 523808
2.
广东医科大学附属东莞第一医院，东莞 523710
3.
广东医科大学附属医院，湛江 524000
4.
湛江市卫生健康局，湛江 524013
5.
广东医科大学公共卫生与健康研究院，湛江 524023

基金项目:

国家自然科学基金 82273709

广东省教育厅新冠肺炎疫情防控科研专项 2020KZDZX1099

详细信息

通讯作者:
曾志嵘，E-mail: zengzr@gdmu.edu.cn

中图分类号: R181.3
计量
- 文章访问数: 415
- HTML全文浏览量: 177
- PDF下载量: 46
- 被引次数: 0
出版历程
- 收稿日期: 2022-12-02
- 修回日期: 2023-02-12
- 网络出版日期: 2023-08-08
- 刊出日期: 2023-07-10

Analysis and model prediction of epidemiological characteristics of main blood-borne and sexually transmitted diseases in Zhanjiang City from 2005 to 2019

1.
Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan 523808, China
2.
The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan 523710, China
3.
Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China
4.
Zhanjiang Municipal Health Bureau, Zhanjiang 524013, China
5.
Institute of Public Health and Wellness, Guangdong Medical University, Zhanjiang 524023, China

Funds:

National Social Science Foundation of China 82273709

COVID-19 Prevention and Control Research Fund of Department of Education of Guangdong Province 2020KZDZX1099

More Information

Corresponding author: ZENG Zhirong, E-mail: zengzr@gdmu.edu.cn

摘要

摘要: 目的探讨湛江市5种血源及性传播疾病的发病特征，建立求和自回归移动平均(autoregressive integrated moving average, ARIMA)模型预测其月发病率，为制定防控策略提供依据。方法收集湛江市2005-2019年5种血源及性传播疾病的报告病例数，分析其流行特征，并为每种疾病构建ARIMA模型。结果湛江市2005-2019年累计报告血源及性传播疾病154 477例，年均发病率为148.54/10万，发病率呈长期上升趋势，男性发病数多于女性，主要发生在20~＜40岁年龄段，高发人群为农民，好发于廉江市，2月呈发病低谷期。乙型病毒性肝炎(乙肝)、丙型病毒性肝炎(丙肝)、HIV/AIDS、淋病最优模型均为ARIMA(0, 1, 1)(0, 1, 1)₁₂，梅毒最优模型为ARIMA(0, 1, 1)(1, 1, 1)₁₂，2019年拟合值与真实值的平均绝对百分比误差(mean absolute percentage error, MAPE)分别为7.76%、7.58%、9.39%、19.60%、11.48%。结论 2005-2019年湛江市血源及性传播疾病有较高的发病率，且发病有明显的地区、人群分布特点; ARIMA模型在血源及性传播疾病中有较好的预测性能，可通过模型进行短期预测，为合理配置防控资源提供依据。
- 血源及性传播疾病 /
- 流行特征 /
- 求和自回归移动平均模型
Abstract: Objective To explore the incidence characteristics of five blood-borne and sexually transmitted diseases in Zhanjiang City, and to establish an autoregressive integrated moving average (ARIMA) model to predict the monthly incidence, thereby offering a basis for formulating prevention and control strategies. Methods We collected the number of reported cases of five blood-borne and sexually transmitted diseases in Zhanjiang City from 2005 to 2019, analyzed the epidemiological characteristics, and constructed an ARIMA model for each disease. Results The cumulative number of reported cases of blood-borne and sexually transmitted diseases in Zhanjiang City from 2005 to 2019 was 154 477, with an average annual incidence rate of 148.54/100 000. The incidence displayed a long-term upward trend and was higher in males than in females. The diseases mainly occurred in the 20- < 40 age group, with a high incidence among farmers, and were predominantly prevalent in Lianjiang City, with a low incidence in February. The optimal model for hepatitis B, hepatitis C, HIV/AIDS, and gonorrhea was ARIMA(0, 1, 1)(0, 1, 1)₁₂, and the optimal model of syphilis was ARIMA(0, 1, 1)(1, 1, 1)₁₂. In 2019, the mean absolute percentage error (MAPE) of the fitted and true values was 7.76%, 7.58%, 9.39%, 19.60% and 11.48%, respectively. Conclusions The incidence of blood-borne and sexually transmitted diseases in Zhanjiang City from 2005 to 2019 was high, characterized by distinct regional and demographic distributions. The ARIMA model demonstrated good predictive performance for these diseases, proving its usefulness for making short-term predictions and providing a basis for rational resource allocation for disease prevention and control.
- Blood-borne and sexually transmitted diseases /
- Epidemic characteristics /
- Autoregressive integrated moving average model

HTML全文

图 1 2005-2019年湛江市血源及性传播疾病时间分布图

1. A：乙肝; 2. B：丙肝; 3. C：梅毒; 4. D：HIV/AIDS; 5. E：淋病; 6. a：时间趋势; 7. b：月份分布。

Figure 1. Time distribution map of blood-borne and sexually transmitted diseases in Zhanjiang City from 2005 to 2019

1. A: Hepatitis B; 2. B: Hepatitis C; 3. C: Syphilis; 4. D: HIV/AIDS; 5. E: Gonorrhea; 6. a: Time trend; 7. b: Month distribution.

下载: 全尺寸图片幻灯片

图 2 2020年湛江市血源及性传播疾病月发病率预测图

1. A: 乙肝; 2. B：丙肝; 3. C：梅毒; 4. D：HIV/AIDS; 5. E：淋病。

Figure 2. Monthly incidence prediction of blood-borne and sexually transmitted diseases in Zhanjiang City in 2020

1. A: Hepatitis B; 2. B: Hepatitis C; 3. C: Syphilis; 4. D: HIV/AIDS; 5. E: Gonorrhea.

下载: 全尺寸图片幻灯片

表 1 2005-2019年湛江市血源及性传播疾病不同性别分布情况

Table 1. Distribution of blood-borne and sexually transmitted diseases in Zhanjiang City by gender from 2005 to 2019

病种Disease	男性^① Male ^①	女性^① Female ^①	男女性别比Male to female sex ratio
乙肝Hepatitis B	72 673(71.18)	29 422(28.82)	2.47∶1
丙肝Hepatitis C	9 727(77.25)	2 865(22.75)	3.40∶1
梅毒Syphilis	17 539(55.97)	13 797(44.03)	1.27∶1
HIV/AIDS	3 288(77.02)	981(22.98)	3.35∶1
淋病Gonorrhea	3 377(80.69)	808(19.31)	4.18∶1
注：①以[人数(占比/%)]表示。 Note：① [Number of people (proportion /%)].

下载: 导出CSV

表 2 2005-2019年湛江市血源及性传播疾病不同年龄分布情况

Table 2. Distribution of blood-borne and sexually transmitted diseases in Zhanjiang City by ages from 2005 to 2019

年龄组/岁Age group/years	乙肝^① Hepatitis B ^①	丙肝^① Hepatitis C ^①	梅毒^① Syphilis ^①	HIV/AIDS ^①	淋病^① Gonorrhea^①
0~＜10	661(0.65)	214(1.70)	923(2.94)	34(0.80)	40(0.96)
10~＜20	5 680(5.56)	113(0.90)	605(1.93)	99(2.32)	284(6.79)
20~＜30	24 582(24.08)	1 286(10.21)	4 033(12.87)	709(16.61)	1 575(37.63)
30~＜40	21 133(20.70)	4 385(34.82)	4 505(14.38)	745(17.45)	905(21.63)
40~＜50	17 180(16.83)	3 741(29.71)	4 089(13.05)	584(13.68)	519(12.40)
50~＜60	15 347(15.03)	1 380(10.96)	4 515(14.41)	717(16.80)	440(10.51)
60~＜70	10 431(10.22)	707(5.62)	5 202(16.60)	821(19.23)	262(6.26)
70~＜80	5 181(5.07)	450(3.57)	4 859(15.51)	439(10.28)	119(2.84)
≥80	1 900(1.86)	316(2.51)	2 605(8.31)	121(2.83)	41(0.98)
注：①以[人数(占比/%)]表示。 Note：① [Number of people (proportion /%)].

下载: 导出CSV

表 3 2005-2019年湛江市血源及性传播疾病地区分布情况

Table 3. Regional distribution of blood-borne and sexually transmitted diseases in Zhanjiang City from 2005 to 2019

地区District	乙肝^① Hepatitis B ^①	丙肝^① Hepatitis C ^①	梅毒^① Syphilis ^①	HIV/AIDS ^①	淋病^① Gonorrhea^①
赤坎区Chikan District	6 595(6.46)	943(7.49)	2 617(8.35)	213(4.99)	298(7.12)
雷州市Leizhou City	15 135(14.82)	1 437(11.41)	4 535(14.47)	314(7.36)	987(23.59)
廉江市Lianjiang City	17 696(17.33)	2 105(16.72)	6 895(22.00)	1 874(43.90)	704(16.82)
麻章区Mazhang District	6 525(6.39)	1 092(8.67)	1 928(6.15)	255(5.97)	175(4.18)
坡头区Potou District	5 349(5.24)	496(3.94)	1 376(4.39)	174(4.08)	211(5.04)
遂溪县Suixi County	15 612(15.29)	1 973(15.67)	4 754(15.17)	419(9.81)	450(10.75)
吴川市Wuchuan City	9 107(8.92)	946(7.51)	2 704(8.63)	389(9.11)	499(11.92)
霞山区Xiashan District	8 733(8.56)	1 350(10.72)	3 182(10.16)	310(7.26)	514(12.28)
徐闻县Xuwen County	17 088(16.74)	2 230(17.71)	3 283(10.48)	320(7.50)	325(7.77)
其他Other	255(0.25)	20(0.16)	62(0.20)	1(0.20)	22(0.53)
注：①以[人数(占比/%)]表示。 Note：① [Number of people (proportion /%)].

下载: 导出CSV

表 4 湛江市血源及性传播疾病最优模型参数值

Table 4. Parameter values of the optimal model of blood-borne and sexually transmitted diseases in Zhanjiang City

模型 Model	参数 Parameter	β	s_x	t值 t value	P值 P value	AIC值 AIC value	残差L-B检验P值 P value of L-B test
乙肝ARIMA(0, 1, 1)(0, 1, 1)₁₂Hepatitis B ARIMA(0, 1, 1)(0, 1, 1)₁₂	MA1	-0.42	0.08	-5.25	<0.001	449.08	0.99
	SMA1	-0.89	0.10	-8.90	< 0.001
丙肝ARIMA(0, 1, 1)(0, 1, 1)₁₂Hepatitis C ARIMA(0, 1, 1)(0, 1, 1)₁₂	MA1	-0.72	0.07	-10.29	< 0.001	-103.82	0.82
	SMA1	-0.84	0.09	-9.33	< 0.001
梅毒ARIMA(0, 1, 1)(1, 1, 1)₁₂Syphilis ARIMA(0, 1, 1)(1, 1, 1)₁₂	MA1	-0.71	0.06	-11.83	< 0.001	107.21	0.37
	SAR1	0.30	0.12	2.50	0.008
	SMA1	-0.89	0.13	-6.85	< 0.001
HIV/AIDS ARIMA(0, 1, 1)(0, 1, 1)₁₂	MA1	-0.85	-0.05	17.00	< 0.001	-251.46	0.31
	SMA1	-0.75	0.07	-10.71	< 0.001
淋病ARIMA(0, 1, 1)(0, 1, 1)₁₂ Gonorrhea ARIMA(0, 1, 1)(0, 1, 1)₁₂	SAR1	-0.70	0.06	-11.67	< 0.001	-289.99	0.39
	SMA1	-1.00	0.14	-7.14	<0.001
注：ARIMA, 求和自回归移动平均; AIC, 赤池信息量准则; MA, 移动平均模型阶数; SMA, 季节性移动平均模型阶数; SAR, 季节性自回归模型阶数。 Note: ARIMA, auto regressive integrated moving average; AIC, Akaike information criterion; MA, order of moving average model; SMA, order of seasonal moving average model; SAR, order of seasonal auto regressive model.

下载: 导出CSV

参考文献(16)

[1]	王凝芳, 朱观福, 刘玮, 等. 血源传播疾病与性传播疾病[M]. 北京: 人民军医出版社, 1997: 3. Wang NF, Zhu GF, Liu W, et al. Blood-borne and sexually transmitted diseases[M]. Beijing: People's Military Surgeon Publishing House, 1997: 3.
[2]	郑和义. 性传播疾病诊断与治疗[J]. 中国计划生育学杂志, 2002, 10(8): 506-511. DOI: 10.3969/j.issn.1004-8189.2002.08.050. Zheng HY. Diagnosis and treatment of sexually transmit diseases[J]. Chin J Fam Plan, 2002, 10(8): 506-511. DOI: 10.3969/j.issn.1004-8189.2002.08.050.
[3]	World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021[EB/OL]. (2021-07-15)[2022-12-01]. https://www.who.int/publications/i/item/9789240027077 .
[4]	王燕. 时间序列分析——基于R[M]. 北京: 中国人民大学出版社, 2015: 142-160. Wang Y. Time series analysis with R[M]. Beijing: China Renmin University Press, 2015: 142-160.
[5]	王晨, 郭倩, 周罗晶. 基于R语言的ARIMA模型对流感样病例发病趋势的预测[J]. 中华疾病控制杂志, 2018, 22(9): 957-960. DOI: 10.16462/j.cnki.zhjbkz.2018.09.020. Wang C, Guo Q, Zhou LJ. Forecast of incidence trend of influenza-like illness by the ARIMA model based on R[J]. Chin J Dis Control Prev, 2018, 22(9): 957-960. DOI: 10.16462/j.cnki.zhjbkz.2018.09.020.
[6]	Zhu ZX, Zhu XX, Zhan YC, et al. Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011-2021[J]. Front Public Health, 2022, 10: 966813. DOI: 10.3389/fpubh.2022.966813.
[7]	Zou X, Chow EP, Zhao PZ, et al. Rural-to-urban migrants are at high risk of sexually transmitted and viral hepatitis infections in China: a systematic review and meta-analysis[J]. BMC Infect Dis, 2014, 14: 490. DOI: 10.1186/1471-2334-14-490.
[8]	Zhao YP, Luo TY, Tucker JD, et al. Risk factors of HIV and other sexually transmitted infections in China: a systematic review of reviews[J]. PLoS One, 2015, 10(10): e0140426. DOI: 10.1371/journal.pone.0140426.
[9]	谢年华, 王夏, 吴斯, 等. 武汉市HIV/AIDS合并HBV/HCV感染的流行特征和影响因素分析[J]. 华中科技大学学报(医学版), 2019, 48(2): 183-188. DOI: 10.3870/j.issn.1672-0741.2019.02.010. Xie NH, Wang X, Wu S, et al. Epidemiological characteristics and influencing factors of HBV and HCV coinfections among patients with HIV/AIDS in Wuhan City[J]. Acta Med Univ Sci Technol Huazhong, 2019, 48(2): 183-188. DOI: 10.3870/j.issn.1672-0741.2019.02.010.
[10]	王洪琳, 蔡于茂, 蓝丽娜, 等. 深圳市2016年淋病疫情上升的影响因素[J]. 国际流行病学传染病学杂志, 2019, 46(4): 301-305. DOI: 10.3760/cma.j.issn.1673-4149.2019.04.011. Wang HL, Cai YM, Lan LN, et al. Factors associated with the raising prevalence of gonorrhea in Shenzhen in 2016[J]. Inter J Epidemiol Infect Dis, 2019, 46(4): 301-305. DOI: 10.3760/cma.j.issn.1673-4149.2019.04.011.
[11]	魏珊, 陆一涵, 高眉扬, 等. 中国主要法定报告传染病的"春节效应"研究[J]. 复旦学报(医学版), 2013, 40(2): 153-158. DOI: 10.3969/j.issn.1672-8467.2013.02.005. Wei S, Lu YH, Gao MY, et al. "Spring Festival effect" on the main notifiable communicable diseases in China[J]. Fudan Univ J Med Sci, 2013, 40(2): 153-158. DOI: 10.3969/j.issn.1672-8467.2013.02.005.
[12]	连隽, 王文军, 苏小游, 等. 50岁及以上男男性行为人群HIV感染及相关因素分析[J]. 中华流行病学杂志, 2021, 42(4): 668-671. DOI: 10.3760/cma.j.cn112338-20200928-01197. Lian J, Wang WJ, Su XY, et al. HIV infection and related factors among men who have sex with men aged 50 and above[J]. Chin J Epidemiol, 2021, 42(4): 668-671. DOI: 10.3760/cma.j.cn112338-20200928-01197.
[13]	Cao WT, Li R, Ying JY, et al. Spatiotemporal distribution and determinants of gonorrhea infections in mainland China: a panel data analysis[J]. Public Health, 2018, 162: 82-90. DOI: 10.1016/j.puhe.2018.05.015.
[14]	沈忠周, 马帅, 曲翌敏, 等. ARIMA模型在我国法定传染病报告数中的应用[J]. 中华流行病学杂志, 2017, 38(12): 1708-1712. DOI: 10.3760/cma.j.issn.0254-6450.2017.12.025. Shen ZZ, Ma S, Qu YM, et al. Application of autoregressive integrated moving average model in predicting the reported notifiable communicable diseases in China[J]. Chin J Epidemiol, 2017, 38(12): 1708-1712. DOI: 10.3760/cma.j.issn.0254-6450.2017.12.025.
[15]	Yan XY, Wang XC, Zhang XY, et al. The epidemic of sexually ttransmitted diseases under the influence of COVID-19 in China[J]. Front Public Health, 2021, 9: 737817. DOI: 10.3389/fpubh.2021.737817.
[16]	Geng MJ, Zhang HY, Yu LJ, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic[J]. Nat Commun, 2021, 12(1): 6923. DOI: 10.1038/s41467-021-27292-7.